SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants (Journal of Medical Virology, 2017)

(untitled) - Jones, M; Cunningham, M; Wing, P; Desilva, S; Challa, R; Sheri, A; Padmanabhan, S; Iyer, R; Korba, B; Afdhal, N; Foster, G